BIOMAT Database Logo BIOMAT Database Logo

Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins. 1998

E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
McGill University AIDS Centre, Lady Davis Institute-Jewish General Hospital, Montreal, H3T 1E2, Canada.

We have selectively mutagenized specific residues at the junction between the protease (PR) and reverse transcriptase (RT) genes of human immunodeficiency virus type 1 (HIV-1) to study the effects of PR-RT fusion proteins in the context of a full-length, infectious proviral construct. Mutant viruses derived from COS-7 cells transfected with this construct were analyzed in regard to each of viral replication, maturation, and infectivity. Immunoblot analysis revealed that the mutation prevented cleavage between the PR and RT proteins and that both existed as a PR-RT fusion protein in each of cellular and viral lysates. Interestingly, intracellular PR that existed within the PR-RT fusion protein remained functionally active, whereby HIV-1 precursor proteins were processed efficiently. Furthermore, the RT component of the fusion protein also retained its enzymatic activity as shown in RT assays. Electron microscopy revealed that the mutant viruses containing the PR-RT fusion protein possessed wild-type morphology. These viruses also displayed wild-type sensitivities to inhibitors of each of the HIV-1 PR and RT activities. However, viruses containing the PR-RT fusion protein were 20 times less infectious than wild-type viruses. This defect was further pronounced when mutated Gag-Pol proteins were overexpressed as a consequence of an additional mutation that interfered with frameshifting. Thus, unlike cleavage site mutations at the N terminus of PR, a cleavage site mutation between PR and RT did not affect the enzymatic activities of either PR or RT and viruses containing PR-RT fusion proteins were viable.

UI MeSH Term Description Entries
D008854 Microscopy, Electron Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen. Electron Microscopy
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D016333 HIV Protease Enzyme of the human immunodeficiency virus that is required for post-translational cleavage of gag and gag-pol precursor polyproteins into functional products needed for viral assembly. HIV protease is an aspartic protease encoded by the amino terminus of the pol gene. HIV Proteinase,HTLV-III Protease,p16 pol gene product, HIV,p16 protease, HIV,HIV p16 protease,HTLV III Protease,Protease, HIV,Protease, HTLV-III
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse

Related Publications

E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Human Immunodeficiency Virus type 1 reverse transcriptase.
February 1996, Biological chemistry Hoppe-Seyler,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Incorporation of human immunodeficiency virus type 1 reverse transcriptase into virus-like particles.
May 2007, Journal of virology,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins.
September 2001, Life sciences,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Inhibitory effects of antifungal proteins on human immunodeficiency virus type 1 reverse transcriptase, protease and integrase.
January 2002, Life sciences,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase.
January 1995, Methods in enzymology,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.
November 2009, Antimicrobial agents and chemotherapy,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins.
May 2004, Journal of virology,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries.
November 2000, Nature medicine,
E Cherry, and C Liang, and L Rong, and Y Quan, and P Inouye, and X Li, and N Morin, and M Kotler, and M A Wainberg
Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
August 2005, Journal of virology,
Copied contents to your clipboard!